Is it useful to articulate every moment to moment doubt? Maybe things just take longer than anyone expected or knew. Maybe Leo is in discussions with another Pharma that requires secrecy while details get worked out. Maybe the RBL researcher was delayed or found something else useful to investigate before writing up her report for peer review. Maybe it was all a ruse to keep the money flow coming so Leo lied about timelines and data?
Your comments include a number of negative assumptions such as, "It doesn't seem like we are making it to in vivo through the RBL." Because the estimated time frame Leo gave us is currently off by a month does not mean it won't happen. If the B vs. C-19 process wasn't going well, I would expect that he would shift the focus away to other indications/trials with some PR's to keep the fans happy. As far as I'm concerned, the silence is golden and I believe that the next press release will be major positive news. IMO -- Go IPIX!!!
News 
Market Data 
Discover 
